Myelodysplastic syndromes are propagated by rare and distinct human cancer stem cells in vivo (Cancer Cell, 2014)

(untitled) - Woll, P; Kjällquist, U; Chowdhury, O; Doolittle, H; Wedge, D; Thongjuea, S; Erlandsson, R; Ngara, M; Anderson, K; Deng, Q; Mead, A; Stenson, L; et al.